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In cells of higher eukaryotic organisms the activity of the p34cdc2/cyclin B complex is
inhibited by phosphorylation of p34cdc2 at two sites within its amino-terminus (threonine
14 and tyrosine 15). In this study, the cell cycle regulation of the kinases responsible for
phosphorylating p34cdc2 on Thr14 and Tyrl5 was examined in extracts prepared from both
HeLa cells and Xenopus eggs. Both Thr14- and Tyr15- specific kinase activities were reg-
ulated in a cell cycle-dependent manner. The kinase activities were high throughout in-
terphase and diminished coincident with entry of cells into mitosis. In HeLa cells delayed
in G2 by the DNA-binding dye Hoechst 33342, Thrl4- and Tyr15- specific kinase activities
remained high, suggesting that a decrease in Thrl4- and Tyr15- kinase activities may be
required for entry of cells into mitosis. Similar cell cycle regulation was observed for the
Thrl4/Tyrl5 kinase(s) in Xenopus egg extracts. These results indicate that activation of
CDC2 and entry of cells into mitosis is not triggered solely by activation of the Cdc25
phosphatase but by the balance between Thrl4/Tyrl5 kinase and phosphatase activities.
Finally, we have detected two activities capable of phosphorylating p34cdc2 on Thrl4 and/
or Tyri5 in interphase extracts prepared from Xenopus eggs. An activity capable of phos-
phorylating Tyrl5 remained soluble after ultracentrifugation of interphase extracts whereas
a second activity capable of phosphorylating both Thr14 and Tyrl5 pelleted. The pelleted
fraction contained activities that were detergent extractable and that phosphorylated p34cdc2
on both Thrl4 and Tyr15. The Thr14- and Tyr15-specific kinase activities co-purified
through three successive chromatographic steps indicating the presence of a dual-specificity
protein kinase capable of acting on p34cdc2.
INTRODUCTION
In proliferating cells, the phosphorylation state of p34cdc2
changes in a cell cycle-dependent manner. p34cdc2 iS
progressively phosphorylated on tyrosine (Tyr15) and
threonine (Thrl4 and Thrl61) residues beginning in S
phase and peaking in late G2 phase (Draetta and Beach,
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1988; Draetta et al., 1988; Morla et al., 1989; Krek and
Nigg, 1991). Phosphorylation of p34cdc2 on tyrosine and
threonine residues occurs in a cyclin-dependent manner
(Solomon et al., 1990; Meijer et al., 1991; Parker et al.,
1991; Solomon et al., 1992; Atherton-Fessler et al.,
1993). At the G2/M phase transition, p34cdc2 is de-
phosphorylated on tyrosine 15 and threonine 14, but
not on threonine 161 (Draetta et al., 1988; Dunphy and
Newport, 1989; Gautier et al., 1989; Morla et al., 1989;
Solomon et al., 1990; Krek and Nigg, 1991; Norbury et
al., 1991). It is the abrupt dephosphorylation of Tyri5
and Thrl4 that leads to activation of the p34cdc2 kinase
and entry of cells into mitosis (Dunphy and Newport,
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1989; Gautier et al., 1989; Morla et al., 1989; Solomon
et al., 1990; Krek et al., 1991; Norbury et al., 1991).
Following the degradation of cyclin B and exit of cells
from mitosis, Thrl61 is dephosphorylated during early
Gl (Lorca, 1992). Thus it is clear that p34cdc2 iS phos-
phorylated and dephosphorylated at specific points in
the cell cycle, but it is less clear what determines the
timing of these phosphorylation and dephosphorylation
events.
In Schizosaccharomyces pombe, the phosphorylation
of Tyrl5 is regulated by protein kinases encoded by
weel+ and mikl+ (Russell and Nurse, 1987; Lundgren
et al., 1991). weel+ encodes a 107 kDa protein kinase
that directly phosphorylates p34cdc2 on Tyrl5 (Feath-
erstone et al., 1991; Parker et al., 1991, 1992), while
mikl+ encodes a putative protein kinase that is also in-
volved in maintaining p34Cdc2 in its tyrosine phosphor-
ylated and inactive state (Lundgren et al., 1991). Another
mitotic control gene identified in S. pombe, cdc25+, en-
codes a mitotic inducer and p34cdc2 activator, which di-
rectly dephosphorylates p34cdc2 on Tyrl5 (Russell and
Nurse, 1986; Millar et al., 1991a). The protein-tyrosine
phosphatase encoded by pyp3+ can functionally sub-
stitute for cdc25+ in the dephosphorylation of p34cdc2
on Tyrl5 (Millar et al., 1992). Functional homologs of
cdc25+ have been identified in a variety of species and
have been shown to encode phosphatases capable of
dephosphorylating p34cdc2 on Tyrl5, as well as Thrl4
(Dunphy et al., 1991; Gautier et al., 1991; Strausfeld et
al., 1991; Lee et al., 1992; Sebastian et al., 1993).
A human homolog of weel+ was cloned based on its
ability to complement weel+ mutants of S. pombe (Igar-
ashi et al., 1991). Given that S. pombe weel+ encodes
a protein kinase capable of phosphorylating serine,
threonine, and tyrosine residues in vitro, the possibility
arose that weel+ from higher eukaryotes might encode
a true dual-specificity kinase that would phosphorylate
p34cdc2 on both Tyrl5 and Thrl4. However, the human
homolog of weel+ was shown to encode a tyrosine-spe-
cific protein kinase that phosphorylates p34cdc2 only on
Tyrl5 in vitro (Honda et al., 1992; Parker and Piwnica-
Worms, 1992; McGowen and Russell, 1993). Thus a
second inhibitory kinase must exist in higher eukaryotes
that is responsible for phosphorylating p34cdc2 on Thr14.
At this time, it is unknown whether this kinase is a
serine/threonine-specific kinase that phosphorylates
p34cdc2 only on Thrl4, or whether it might in fact be a
dual-specificity kinase capable of phosphorylating both
Thrl4 and Tyrl5.
The phosphorylation of p34cdc2 on Thrl4, Tyrl5, and
Thrl61 during S and G2 parallels the synthesis and
accumulation of cyclin B, a finding which reinforces the
model that cyclin binding potentiates phosphorylation
of p34cdc2. Thus the timing of phosphorylation of p34cdc2
is limited to some extent by the synthesis of its regulatory
subunit, cyclin B. Regulation of the kinases (i.e., Weel
and Mikl) and phosphatases (i.e., Cdc25), which act
directly on p34cdc2 represents another potential means
by which the timing of critical phosphorylation/de-
phosphorylation events is determined.
In S. pombe and Drosophila, both the mRNA and pro-
tein levels of Cdc25 oscillate during the cell cycle, peak-
ing at mitosis (Edgar and O'Farrell, 1989; Ducommun
et al., 1990; Edgar and O'Farrell, 1990; Moreno et al.,
1990). Thus in these organisms the synthesis of Cdc25
mRNA and protein determines the timing of dephos-
phorylation and activation of p34cdc2. In Xenopus and
humans, however, the abundance of Cdc25 remains
constant throughout the cell cycle (Millar et al., 1991b;
Izumi et al., 1992; Jessus and Beach, 1992; Kumagai and
Dunphy, 1992). Cdc25 has been shown to physically
associate with cyclin B in both Xenopus and human cells
(Galaktionov and Beach, 1991; Jessus et al., 1992), and
this association may be rejuired for the efficient de-
phosphorylation of p34cdc (Zheng and Ruderman,
1993). Thus dephosphorylation of p34cdc2 by Cdc25 may
also be regulated by the formation of the p34cdc2/cyclin
B complex. In addition, Cdc25 is phosphorylated in a
cell cycle dependent manner, with maximal phosphor-
ylation occurring during M phase (Izumi et al., 1992;
Kumagai and Dunphy, 1992; Hoffmann et al., 1993).
The phosphorylation of Cdc25 is associated with an
increase in its phosphatase activity, which is reversible
by dephosphorylation in vitro (Izumi et al., 1992; Ku-
magai et al., 1992; Hoffmann et al., 1993).
Fission yeast plo7weel is negatively regulated by the
cdrl/niml protein kinase, which phosphorylates
plO7weel within its catalytic domain (Coleman et al.,
1993; Parker et al., 1993; Wu and Russell, 1993). Recent
evidence from Tang et al. (1993) suggests that when
fission yeast plo7weel (overproduced in insect cells) is
mixed with M phase Xenopus egg extracts, its kinase
activity is inhibited, and this inhibition is due to phos-
phorylation of its amino-terminal end (on sites distinct
from those phosphorylated by the cdrl/niml ki-
nase)(Tang et al., 1993). These results corroborate an
earlier report by Smythe and Newport (1992), which
showed that M phase Xenopus egg extracts possessed
diminished p34cC2-specific tyrosine kinase activity when
compared with S phase extracts (Smythe and Newport,
1992). It has not been determined whether similar
mechanisms of regulation hold true for mammalian
cells. Further, these studies have been limited to the
regulation of phosphorylation of p34cdc2 at Tyrl5. Vir-
tually nothing is known about the regulation of the ki-
nase responsible for the phosphorylation of p34cdc2 on
Thrl4.
We have developed an assay system where the reg-
ulation of the kinases responsible for phosphorylating
p34cdc2 on Thrl4 and Tyrl5 can be studied in vitro. We
report that the Thrl4- and Tyrl5-specific kinase activ-
ities are coordinately regulated in a cell cycle-dependent
manner in both HeLa cells and in extracts prepared from
Xenopus eggs. In addition, we have used this assay sys-
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tem to begin to purify the Thr14- and Tyrl5-specific
kinases from interphase extracts prepared from Xenopus
eggs.
MATERIALS AND METHODS
All procedures relating to Sf9 insect cell culture, generation of recom-
binant baculovirus, and propagation of recombinant baculovirus were
performed as described elsewhere (Piwnica-Worms, 1990). Recom-
binant viruses encoding p34'(Arg 33) and p34'(Phe 15) have been
described previously (Parker et al., 1991; Atherton-Fessler et al., 1993).
Mutagenesis of cdc2
Site-directed mutagenesis of the human cdc2 gene was performed as
previously described (Parker et al., 1991; Atherton-Fessler et al., 1993).
Single-stranded pSAF20 containing a 679-bp BamHI-HinclI N-terminal
fragment of cdc2 served as the template for mutagenesis of threonine
14 to alanine (p34'c2[Ala 14]), as well as threonine 14 and tyrosine
15 to alanine and phenylalanine, respectively (p34'[Ala14/Phe15J).
The oligonucleotides used in these cases were as follows:
5'-GGAGAAGGTGCCTATGGAGTTGTG-3' (Thrl4 to Alal4) and 5'-
AGAAGGTGCCTTTGGAGTTGTGTA-3' (Thr14/Tyrl5 to Alal4/
Phel5).
The wild-type cdc2 N-terminus of pSAF10 was then replaced with
the mutant N-termini to generate full-length cdc2(Alal4) and
cdc2(Alal4/Phel5). Mutations wvere confirmed by dideoxynucleotide
sequencing and a 1.2 kb BamHI to EcoRI fragment encoding each
mutant was cloned into pVL1393 for the generation of recombinant
baculoviruses as described (Piwnica-Worms, 1990).
Labeling of Sf9 Cells In Vivo
Insect cells infected with recombinant baculovirus were rinsed once
with methionine-free Graces medium and then resuspended in me-
thionine-free medium supplemented with 2 mM glutamine, 1.5% di-
alyzed calf serum, and 0.30-0.35 mCi/ml 35S-Express protein label
(NEN/DuPont); - 1.5 X 107 cells/ml. Cells were rocked at room tem-
perature (25°C) for 3-4 h., then rinsed once in phosphate-buffered
saline and stored as cell pellets at -80°C.
Preparation of Insect Cell Lysates
Insect cells were lysed in Nonidet P-40 (NP-40)/tris (hydroxymethyl)
aminomethane (Tris) buffer [50 mM Tris (pH 7.4), 0.25 M NaCl, 50
mM NaF, 10 mM sodium pyrophosphate (NaPPi), 0.1% NP40, 10%
glycerol] supplemented with 1 mM sodium orthovanadate, 0.15 U/
ml of aprotinin, 20 MM pepstatin, and 20 MM leupeptin. Cell lysates
were clarified at 10 000 X g for 15 min.
HeLa Cell Culture and Synchronization
HeLa cells were cultured in Dulbecco's modified Eagle's medium
(DMEM) (GIBCO, Grand Island, NY) with 10% calf serum (Sigma,
St. Louis, MO). The double thymidine block release was performed
essentially as described for the thymidine/aphidicolin double block
release (Motokura et al., 1991). Briefly, HeLa cells were grown to
confluence, then incubated 16 h with 2 mM thymidine (Sigma). The
cells were washed twice with Hank's balanced salt solution and tryp-
sinized off the plates. Collected cells were then reseeded at - 4 X 106
cells per 100 mm tissue culture dish in DMEM/10% calf serum sup-
plemented with 24 MM each of thymidine and deoxycytidine (Sigma)
and incubated for 8 h. Cells were then incubated for a further 16 h
in the presence of 2 mM thymidine. The plates were washed three
times with prewarmed (37°C) DMEM and cultured in DMEM/10%
calf serum for 0 to 14 h, as indicated in the appropriate figure legends
(Figures 3 and 4). At the indicated times, plates were washed with
ice cold phosphate-buffered saline (PBS), and stored at -80°C until
use. Nocodazole arrested cells were obtained by incubating cells in
the presence of 0.1 Mg/ml nocodazole (Sigma) for 10 to 18 h. Mitotic
cells were then collected by mitotic shake off. Cells were delayed in
G2 by the addition of 7.5 ug/ml Hoechst 33342 (Calbiochem, San
Diego, CA) 4 h after release from a double thymidine block (Crissman
et al., 1990). Plates were frozen at -80°C until needed. Immunopre-
cipitation assays (histone Hi kinase assays) or phosphorylation (shift)
assays were performed as described below. For histone Hi kinase
assays, HeLa cells were lysed in modified NETN buffer (20 mM Tris
pH 8.0, 1 mM EDTA, 0.5% NP-40, 0.4 M NaCl, 10 mM NaF, 0.1 mM
sodium vanadate, 2 mM dithiothreitol (DTT) and 5 MAM microcystin
(Gibco-BRL). For the Thr14/Tyrl5 phosphorylation (shift) assays,
HeLa cells were lysed in buffer consisting of 50 mM Tris pH 7.5, 5
mM EDTA, 2 mM DTT, 10 mM NaF, 0.1 mM sodium vanadate, 250
mM NaCl and 0.1% Brij-35.
Histone Hi Kinase Assays (HeLa Cells)
Approximately 4 X 106 HeLa cells (at different points in the cell cycle)
were lysed in 1 ml of a modified NETN buffer (as described above).
Anti-cyclin B serum (2.0 ,ul) (Atherton-Fessler et al., 1993) was added
to 50 Ml of lysate, the reaction was brought up to 300 Ml with NETN
buffer [20 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5% NP-
40] containing 1 mM sodium orthovanadate, 0.15 U/ml of aprotinin,
20 zMMpepstatin, and 20 MM leupeptin. Reactions were incubated for
2 h at 4°C. Twenty microliters of 50% slurry of Sepharose CL-4B
protein A beads were added, and the immunoprecipitation was con-
tinued for 1 h at 4°C. Immunoprecipitates were washed twice in
NETN, twice in NETN containing 1 mM NaCl, and twice in incomplete
kinase buffer (50 mM Tris pH 7.4, 10 mM MgCl2, 5 mM DTT). Forty
microliters of complete kinase buffer [50 mM Tris (pH 7.4), 10 mM
MgCl2, 5 mM dithiothreitol, 0.4 Mug/ml histone Hi, 10 ,M ATP and
0.5 to 1.0 mCi/ml _y32P-labeled ATP] was added to the washed im-
munoprecipitates and reactions were incubated at 30°C for 10 min.
Reactions were terminated by the addition of sodium dodecyl sulfate
(SDS)-sample buffer, and the reaction products were resolved by SDS-
polyacrylamide gel electrophoresis (PAGE). Phosphorylation of his-
tone Hi was detected by autoradiography and quantitated by Cher-
enkov counting in a liquid scintillation counter.
Thrl4/Tyrl5 Phosphorylation (Shift) Assays
(HeLa Cells)
Lysates were prepared from insect cells infected with recombinant
viruses encoding p34' (either wild-type or mutant forms) and labeled
in vivo with 35S-methionine. These (3S)p34Cdc-containing lysates were
combined with insect cell lysates containing GST-cyclin B and incu-
bated in the presence of 10 mM MgCl2 and 1 mM ATP for 30 min at
25°C to allow for efficient formation of (35S)p34cdc2/GST-cycin B
complexes. (3S)p34'2/GST-cyclin B complexes were precipitated with
glutathione agarose, and the precipitates were washed twice with
NP-40/Tris buffer, and three times with Q buffer [QB: 20 mM trieth-
anolamine-HCl, (pH 7.6) 50 mM NaCl, 2 mM EDTA, 1 mM DTT, 5
mM sodium fluoride, 1 mM sodium pyrophosphate] containing 0.05%
Brij-35 (SurfactAmps; Pierce, Rockford, IL) prior to use as a substrate
for Thr14 and/or Tyrl5 phosphorylation in vitro. Approximately 1
to 3 Mg of p34tXI2 protein was present in each assay. HeLa cell lysates
were added to (35S)p34Cdc2/GST-cyclin B complexes, and phosphor-
ylation reactions were initiated by the addition of 1/10 volume of
reaction mixture consisting of QB(+0.05% Brij-35) supplemented with
100 mM MgCl2, 10 mM sodium orthovanadate, and 20 mM ATP
(final concentrations 10 mM MgCl2, 1 mM sodium orthovanadate,
and 2 mM ATP). HeLa cell lysates were normalized for total cell
protein for Figure 3 (1.0 mg per condition). In Figure 4, several tissue
culture dishes were seeded with -4 X 106 S-phase arrested cells
(after the double thymidine block), and one plate was harvested for
each shift assay. Protein concentrations ranged from 1.0 to 2.0 mg
throughout the course of the experiment. We typically measured a
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15 to 20% increase in total cellular protein from cells harvested early
in the time course (S and G2) as compared with those harvested later
(M and early Gl). Typical reaction volumes ranged from 0.5-1.0 ml
depending on the protein concentration of HeLa lysates. Reactions
were allowed to proceed at 25°C for 30-45 min., after which the
(35S)p34cdc2/GST-cycin B precipitates were washed twice with 0.5 M
LiCl in 20 mM Tris pH 8.0. Precipitates were solubilized in SDS-
sample buffer and boiled for 3-5 min. Proteins were resolved by SDS-
PAGE (12% acrylamide gels) and visualized by Coomassie blue stain-
ing. (35S)p34CdC2 was visualized and quantitated by autoradiography
or PhosphorImage scanning.
Xenopus Egg Extracts
The following buffers were used routinely in the preparation of extracts
from Xenopus eggs: XB [10 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid (HEPES), pH 7.7, 100 mM KCl, 0.1 mM CaCl2,
1 mM MgCl2, and 50 mM sucrose], MMR (5 mM HEPES, pH 7.8,
100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, and 0.1 mM
EDTA). Xenopus egg extracts were prepared essentially as described
(Murray and Kirschner, 1989), with minor modifications. Briefly, to
prepare CSF-arrested (M-phase) extracts, Xenopus eggs were dejellied
in 2% cysteine, pH 7.8, and transferred into XB containing 5 mM
EGTA, 10 ,ug/ul of pepstatin A and chymostatin, and 100 ,g/ul of
cytochalasin B. Eggs were centrifuged for 3 min at 400 X g to remove
excess buffer. Packed eggs were then crushed by centrifugation for
10 min at 10 000 X g in a swinging bucket rotor. The cytoplasmic
layer was removed, placed on ice, and pepstatin A, chymostatin, and
cytochalasin B were added to 10 ug/ul each. Extracts were then cen-
trifuged for 15 min at 15 000 X g (4°C), followed by 15 min at 10 000
X g (4°C) to clarify. Interphase extracts were derived from CSF-arrested
extracts by the addition of 100 Mg/ml cycloheximide and 0.4 mM
CaCl2 and incubation for 40 min at 23°C. Alternatively, interphase
extracts were obtained by activation of dejellied eggs with calcium
ionophore. In this case, dejellied eggs were washed with 0.2X MMR,
and then activated in a minimal volume of 0.2X MMR containing 5
,Mg/ml A23187 for 60 to 90 s. Eggs were washed extensively with
0.2X MMR and incubated for 40 min at 23°C to allow for complete
entry into interphase. Extracts were then prepared as described above
for CSF-arrested extracts. Finally, extracts were aliquoted, frozen, and
stored at -80°C until needed. For time course experiments (Figure
6A), CSF-arrested extracts were activated with 0.4 mM CaCl2 in the
absence of added protease inhibitors or cycloheximide. Aliquots were
removed at the times indicated after activation, quick frozen, and
stored at -80°C. To monitor exit from M-phase into interphase, 3 ,l
of each extract were removed, diluted 10-fold in water, and were
frozen at -80°C for histone Hi kinase assays. Histone Hi assays
were performed for 10 min at 30°C in a final volume of 30,l. Reactions
consisted of 5 Ml of diluted extract, 20 mM HEPES (pH 7.5), 5 mM
EGTA, 15 mM MgCl2, 1 mM DTT, 200 MuM ATP, 10 Ag of histone
Hi, 10 MCi 832P ATP, and 0.2 ug of protein kinase A inhibitor. The
interphase extracts used in figure 6, B and C were a gift from Dr.
Peter Jackson (Dept. Cell Biology, Harvard Medical School) and were
prepared as described by Murray (1991). To two 50 Ml aliquots of
interphase extract (-2 mg each) the following was added: 2.5 MAl of
a 20X energy mix (150 mM phosphocreatine, 20 mM ATP, 2 mM
EGTA, 20 mM MgCl2) and 5 Mul of lOX protease inhibitor mix (0.1
mg/ml each pepstatin A, chymostatin, and leupeptin). The interphase
extract was either incubated alone or in the presence of 2,Ml (14 to 20
Mg) of A90 cyclin (Glotzer et al., 1991) at 23°C for 50 min to generate
a stable mitotic extract. Three milliliters of each extract were removed
for histone Hi kinase assays as described above. The remainder of
each extract was diluted with 350 ,l of QB containing 0.5% Brij-35,
and 100 Mul aliquots were used in shift assays by incubating with
(35S)p34cdc2/GST-cycin B precipitates for various periods of time as
described below.
Thrl4/Tyrl5 Phosphorylation (Shift) Assays
(Xenopus Egg Extracts)
(35S)p34cdc2/GST-cyclhn B complexes were prepared as described above
and washed with QB (+Brij-35). Xenopus egg extracts (1-2 mg total
protein) or samples from selected column fractions were added to(35S)p34cdc2/GST-cycin B complexes and phosphorylation reactions
were initiated by the addition of 1/10 volume of reaction mixture
consisting of QB(+Brij-35) supplemented with 100 mM MgCl2, 10
mM sodium orthovanadate, and 20 mM ATP (final concentrations 10
mM MgCl2, 1 mM sodium orthovanadate, and 2 mM ATP). For the
shift assay shown in Figure 6B, reactions were adjusted to 1 MM mi-
crocystin. Typical reaction volumes ranged from 0.05 to 1.5 ml de-
pending on the protein concentration of samples to be assayed. Re-
actions were allowed to proceed at 25°C for 30-45 min after which
the (35S)p34cdc2/GST-cyclin B precipitates were washed twice with
0.5 M LiCl in 20 mM Tris pH 8.0. Precipitates were solubilized in
SDS-sample buffer and boiled for 3-5 min. Proteins were resolved by
SDS-PAGE (12% acrylamide gels) and visualized by Coomassie blue
staining. (35S)p34cdc2 was visualized by autoradiography or Phos-
phorImage scanning.
Separation of Two Activities in Xenopus EQgQg
Extracts Capable of Phosphorylating p34c c on
Thrl4/Tyrl5
Eggs were collected and washed in 0.1 M NaCl. Interphase extract
prepared as described above, was diluted two- to four-fold with buffer
A (20 mM HEPES pH 7.6, 10% glycerol, 1 mM EDTA, 5 mM NaF, 1
mM sodium pyrophosphate) containing 50 mM NaCl, 1 mM DTT,
0.1 U/ml aprotinin, 10 MuM pepstatin, and 10 MuM leupeptin and was
centrifuged at 150 000 X g for 20 min at 4°C. The supematant was
saved and referred to as 150S. The pellet (150P) was solubilized in
buffer A containing 0.05% Brij-35 (Pierce) and placed on ice for 20
min prior to recentrifugation at 150 000 X g. The pellet from the
second centrifugation was further extracted with buffer A containing
0.2 and 0.5% of Brij-35 as described above. Alternatively, the 150 000
X g pellet was extracted with buffer A containing 0.1 and 0.5% Triton
X-100.
To purify Thrl4 kinase activity from Xenopus extract, the 150 000
X g pellet was washed in buffer A containing 0.5 M NaCl and protease
inhibitors, centrifuged at 150 000 X g for 20 min, and resolubilized
in buffer A containing 0.5% Brij-35. The tube was placed on ice for
20 min and recentrifuged at 150 000 X g. The supematant (15OP0.5B)
was saved and further fractionated by column chromatography (see
below).
Phosphatase Assays
To characterize the nature of kinase(s) in both the 150 000 X g su-
pematant and the pellet, (35S)-p34cdc2/GST-Cyclin B was precipitated
with glutathione agarose beads and incubated with either 150 000
X g supematant or pellet solubilized with 0.5% Brij-35 under kinase
conditions as described above. The reactions were stopped by washing
the beads two times with gel shift buffer [50 mM Tris (pH 7.4), 50
mM NaCl, 2 mM EDTA, 1 mM DTT, 5 mM sodium fluoride, 1 mM
sodium pyrophosphate containing 0.05% Brij-35] and three times with
phosphatase buffer (50 mM Tris pH 7.4, 2 mM EDTA, 2 mM DTT).
The beads were then resuspended in 400 Ml of phosphatase buffer
and incubated in the presence or absence of 1 Mg of yeast PTP1 phos-
phatase at 25°C for 30 min. The reactions were then washed with
0.5 M LiCl and analyzed on a 12% SDS-PAGE.
Fractionation of Xenopus Egg Extracts
The Thrl4/Tyrl5 kinase activities were solubilized from the 150 000
X g pellet by extraction with buffer A/0.5% Brij-35 as described above(.40-fold purification). A total of 36 ml of 15OP0.5B fraction was
loaded onto a 12 ml Q-Sepharose (Pharmacia, Piscataway, NJ) column
equilibrated with buffer AB [20 mM HEPES (pH 7.6), 10% glycerol,
1 mM EDTA, 5 mM NaF, 1 mM sodium pyrophosphate, 0.05% Brij-
35] containing 50 mM NaCl at a flow rate of 0.5 ml/min. Proteins
bound to the column were eluted with a 100 ml NaCl gradient from
0.05 M to 1 M in buffer AB at 1 ml/min. Three milliliter fractions
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were collected and assayed for the ability to retard the electrophoretic
mobility of (35S)-p34c"c2 in the phosphorylation assay described above
(-3.6-fold purification). The active fractions (eluted at 220 to 450
mM NaCI) were pooled and desalted on a Sephadex G-25 column in
buffer AB and then applied to a 7 ml S-Sepharose (Pharmacia) column
at a flow rate of 0.5 ml/min. Bound proteins were eluted from the
column with buffer AB containing 0.3 M NaCl (S0.3) (-6.5-fold pu-
rification). The SO.3 fraction was desalted in buffer AB to 24 ml in
total volume, and 2 ml of desalted S0.3 were applied to a 1 ml Reactive
Yellow 3 column (Sigma) equilibrated with buffer AB at 0.3 ml/min.
Bound proteins were eluted with a 15 ml gradient of 0 to 1 M NaCl
in buffer AB, and 1 ml fractions were collected and assayed for the
ability to retard the electrophoretic mobility of (35S)-p34cdc2 (-3-fold
purification). The overall purification of the kinase activity was esti-
mated to be -2800-fold.
RESULTS
An In Vitro Assay for Thrl4- and Tyrl5-Specific
Kinase Activities
Human p34cdc2 has been demonstrated to decrease in
electrophoretic mobility upon phosphorylation of either
Thr14 or Tyrl5 residues, with a further decrease in mo-
bility upon phosphorylation of both Thr14 and Tyr15
(Solomon et al., 1992). Thus changes in the electropho-
retic mobility of p34cdc2 can be used as a measure of
changes in its state of phosphorylation at Thr14 and
Tyr15. Phosphorylation of Thrl61 does not result in a
detectable change in the electrophoretic mobility of
p34cdc2. We took advantage of this fact to develop an
assay that monitors the activities of Thr14- and Tyr15-
specific kinases in HeLa cell lysates. To obtain a substrate
for these kinases, insect cells overproducing p34cdc2
(either wild-type or mutant forms) were labeled with
35S-methionine in vivo. Lysates prepared from these
35S-labeled cells were then combined with lysates from
insect cells producing cycin B fused with the glutathione-
S-transferase protein, GST-cyclin B, and the resulting
p34Cdc2/GST-cycin B complexes were isolated using glu-
tathione agarose chromatography. By forming p34 c2/
GST-cyclin B complexes in vitro, we could obtain large
amounts of protein substrate in which only the p34 c2
component was radioactively labeled. In addition, iso-
lation of complexes by virtue of the GST-cyclin B fusion
protein insures that 100% of the p34cdc2 isolated is as-
sociated with cyclin B and therefore is a preferred sub-
strate for phosphorylation (Solomon et al., 1990; Meijer
et al., 1991; Parker et al., 1991, 1992).
The Thrl4 and Tyrl5 kinase activities of HeLa cells
were assayed by mixing HeLa cell lysates with(35S)p34cdc2/GST-cycln B complexes in the presence of
MgATP. Inhibitors of both tyrosine- and serine/thre-
onine-specific protein phosphatases were included in
the reactions so that it was possible to specifically mon-
itor the activities of the Thr14/Tyrl5 kinases. Phos-
phorylation of Thr14 and Tyrl5 was then assessed by
monitoring the electrophoretic mobility of the 35S-la-
beled p34cdc2. As shown in Figure 1, upon incubation
with HeLa cell lysate, p34cdc2 shifts from a single elec-
WT 33R 14A 1SF 14A15F
+ - + - + - + - +
Xp34cdC2
Figure 1. p34Cdc2 is phosphorylated on Thrl4 and Tyrl5 in HeLa cell
lysates. Insect cells producing wild-type 34 Ic2 (WT, lanes 1 and 2),
p34Cdc2(Arg33) (33R, lanes 3 and 4), p34 (Alal4) (14A, lanes 5 and
6), p34Cdc (Phel5) (15F, lanes 7 and 8), or p34'c2(Ala14Phe15)
(14A15F, lanes 9 and 10) were labeled in vivo with 35S-methionine,
lysed and combined with lysates from insect cells expressing GST-
cyclin B. p34c2/GST-cyclin B complexes were precpitated with glu-
tathione agarose beads, and precipitates were incubated for 45 min
at 25°C with buffer alone (-, lanes 1, 3, 5, 7, and 9) or with HeLa
cell extract (+, lanes 2, 4, 6, 8, and 10). Proteins were resolved by
SDS-PAGE and 35S-labeled p34' was visualized by autoradiography.
trophoretic form at 34 kDa (lane 1) to three electropho-
retic forms (lane 2) indicative of phosphorylation on
either Thr14 and Tyr15. The middle band seen in lane
2 contains p34cdc2, which is phosphorylated on Thrl4
or Tyrl5, while the topmost band contains p34cdc2
phosphorylated at both sites (see below). A kinase-de-
ficient form of p34cdc2, p34cdc2(Arg33) (lanes 3 and 4),
underwent a comparable shift in electrophoretic mo-
bility after incubation with HeLa cell lysate (lane 4). To
confirm that the observed shift in electrophoretic mo-
bility corresponds to phosphorylation of p34(XI2 at Thr14
and Tyr15, the mobilities of nonphosphorylatable forms
of p34cdc2 were examined after incubation alone or in
the presence of HeLa cell lysate. When Thrl4 is changed
to Ala to generate p34cdc2(Ala14) (lanes 5 and 6), p34cdc2
undergoes a single shift in electrophoretic mobility (lane
6) in the presence of HeLa cell lysate, indicative of
phosphorylation at Tyrl5. Likewise, when Tyrl5 is
changed to Phe, p34cdc2(Phel5) (lanes 7 and 8), a single
shift in mobility is observed (lane 8), indicative of phos-
phorylation at Thrl4. If both Thr14 and Tyri5 are mu-
tated, to Ala and Phe, respectively, the electrophoretic
mobility 'of p34cdc2 is no longer affected by incubation
with HeLa cell lysate (lanes 9 and 10). Thus phosphor-ylation of p34'di at Thrl4 and/or Tyrl5 can be assessed
by monitoring the electrophoretic mobility of (31S)p34cdc2
(either wild-type or mutant forms). In addition, these
results indicate that phosphorylation of Thr14 and
Tyrl5 can occur independent of one another.
Dependence of Thrl4/Tyrl5 Phosphorylation on
HeLa Cell Protein Concentration
As shown in Figure 2 (top panel), with increasing
amounts of HeLa cell protein, p34cdc2(Arg33) shifts from
a single electrophoretic form at 34 kDa to three electro-
phoretic forms indicative of phosphorylation at Thr14
and Tyr15. With the addition of 0.5 mg of HeLa cell
protein, -30% of p34cdc2(Arg33) was phosphorylated
on one or both sites (as indicated by a decrease in elec-
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Figure 2. Dependence of Thrl4- and Tyrl5-specific kinase activities
on concentration of HeLa cell lysates. Protein preciitates containing
p34CdC2(Arg33) (top), p34cdC2(Phel5) (middle), or p34 c2(Ala14) (bottom)
in comlex with GST-cyclin B were prepared as described in Figure
1. p34 c/GST-cyclin B complexes were incubated for 30 min at 25°C
with varying amounts of HeLa cell lysate (0-4 mg total protein). Pro-
teins were resolved by SDS-PAGE and 35S-labeled p34cdc2 was visu-
alized by autoradiography.
trophoretic mobility), and this fraction increased to
>80% with the addition of 2 mg of HeLa protein. Phos-
phorylation of p34cdc2(Arg33) followed saturation ki-
netics up to 2 mg of HeLa cell protein. At the highest
concentration of HeLa cell protein (4 mg in this exper-
iment), the p34cdc2(Arg33)/GST-cyclin B substrate be-
gan to elute from the glutathione agarose, leading to a
slight decrease in detected kinase activity.
To monitor the Thrl4 and Tyrl5 kinase activities in-
dependently, either p34cdc2(Phel5) or p34cdc2(Alal4)
were assayed with varying amounts of HeLa cell protein.
As shown in Figure 2 (middle), when p34cdc2(Phel5) is
incubated with increasing amounts of HeLa cell protein,
it becomes progressively phosphorylated on Thrl4, as
indicated by the appearance of a slower electrophoretic
form. Similarly, p34cdc2(Alal4) becomes progressively
phosphorylated on Tyrl5 with increasing amounts of
HeLa cell protein (Figure 2, bottom). These results in-
dicate that the protein concentration dependence of both
activities are comparable, with maximal phosphoryla-
tion occurring at 1 to 2 mg HeLa protein. Thus, for
experiments designed to detect potential differences in
the Thr14 and/or Tyrl5 kinase activities, an assay of
0.5 to 1 mg of HeLa lysate was judged to be within the
linear range of both kinase activities.
Cell Cycle Regulation of Thrl4- and Tyrl5-Specific
Kinase Activities in HeLa Cells
During a normal cell division cycle, p34cdc2/cyclin B
complexes begin to accumulate during late S phase,
and these complexes are maintained in an inactive state
by phosphorylation at Thrl4 and Tyri5 (Draetta and
Beach, 1988; Draetta et al., 1988; Dunphy and Newport,
1989; Gautier et al., 1989; Morla et al., 1989; Solomon
et al., 1990; Krek et al., 1991; Norbury et al., 1991). At
the transition from G2 to M phase, Thrl4 and Tyrl5
are rapidly dephosphorylated and p34cdc2 is activated
as a protein kinase (Dunphy and Newport, 1989; Gau-
tier et al., 1989; Morla et al., 1989; Solomon et al., 1990;
Krek et al., 1991; Norbury et al., 1991). We wished to
determine whether the Thrl4- and Tyrl5-specific kinase
activities present in HeLa cells are regulated in a cell
cycle dependent manner. In Figure 3, HeLa cells were
tested at various stages of the cell cycle for their ability
to phosphorylate p34cdc2 at Thrl4 and/or Tyrl5 using
the assay described above. HeLa cells were synchro-
nized in S phase by a double thymidine block and were
then released and allowed to proceed through G2 into
mitosis (M) or were delayed in G2 with theDNA binding
dye, Hoechst 33342. Lysates prepared from aynchron-
ous HeLa cells were capable of phosphorylating
p34cdc2(Arg33) on both Thrl4 and Tyr15, resulting in
the appearance of two retarded electrophoretic forms
(Figure 3, top panel). Interestingly, as shown in Figure
3 (top), lysates prepared from both S phase and G2
phase cells phosphorylated Thrl4 and Tyrl5 to the same
extent as those prepared from asynchronous cells [ - 70-
80% of p34cdc2(Arg33) phosphorylated on one or both
sites]. However, mitotic cells obtained after release from
a double thymidine block possessed significantly less
Thrl4- and/or Tyrl5-specific kinase activity, as judged
by a decrease in the proportion of p34cdc2(Arg33) mi-
grating with a retarded electrophoretic mobility (-35%
phosphorylated; Figure 3, top). If mitotic cells were ob-
tained after a nocodazole arrest, these results were even
more striking, in that p34cdc2(Arg33) was not detectably
phosphorylated on either Thrl4 or Tyrl5 (Figure 3, top)
when compared with controls.
A S G2 MN N
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Figure 3. Phosphorylation of p34cdc2 on Thrl4 and Tyrl5 is diminished
in mitotic HeLa cell lysates. Protein precipitates containingp34CdCi(Arg33) (top), p34Cdc2(Phel5) (middle), or p34:ck2(Alal4) (bottom)
in complex with GST-cyclin B were prepared as described in Figure
1. p34CdC2/GST-cychn B complexes were incubated with lysates pre-
pared from asynchronous HeLa cells (A); HeLa cells synchronized in
S phase (S; double thymidine block); G2 phase (G2; release from
double thymidine into H33342); or mitosis (M; mitotic shake-off fol-
lowing release from double thymidine block); or nocodazole arrested
mitotic HeLa cells (N). Proteins were resolved by SDS-PAGE, and
35S-labeled p34"(c2 was visualized by autoradiography and quantitated
by PhosphorImager.
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Thr14- and Tyr15-specific kinase activities were dis-
tinguished by using p34cdc2(Phel5) and p34cdc2(Alal4)
as substrates for phosphorylation by HeLa cells syn-
chronized in S phase, G2 phase, or mitosis. As in the
case of p34cdc2(Arg33), S- phase and G2-phase cells
readily phosphorylated both p34cdc2(Phel5) (Figure 3,
middle) and p34cdc2(Ala14) (Figure 3, bottom) to the
same extent as asynchronous cells. The phosphorylation
of both p34cdc2(Phel5) and p34cdc2(Alal4) by mitotic
cells decreased by -65%, suggesting that both Thr14-
and Tyr15-specific kinase activities are negatively reg-
ulated at the G2 to M phase transition. Again, these
results were enhanced in nocodazole arrested HeLa
cells, with no detectable phosphorylation of either
p34cdc2(Phel5) or p34cdc2(Ala14) when compared with
controls. These results indicate that the kinase(s) re-
sponsible for phosphorylating p34cdc2 on Thr14 and
Tyrl5 are regulated in a cell cycle dependent manner,
such that both activities are reduced during mitosis.
To more closely examine the cell cycle regulation of
the Thrl4 and Tyrl5 kinase activities, particularly at
the G2/M phase transition, HeLa cell lysates were as-
sayed for their ability to phosphorylate p34cdc2(Arg33)
after release from an S-phase block in the presence or
the absence of the DNA binding dye, Hoechst 33342
(Figure 4A). Entry into mitosis was monitored by as-
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Figure 4. Cell cycle regulation of Thr14- and Tyr15-specific kinase
activities in HeLa cells. HeLa cells were synchronized in S phase by
a double thymidine block (time 0) and then allowed to progress
through G2 and mitosis as described in MATERIALS AND METH-
ODS. (A) p34"c2(Arg33)/GST-cyclin B complexes (where p34"2 was
labeled with 35S-methionine) were incubated with lysates prepared
from HeLa cells that had been collected at various times after release
from an S phase block in the absence (control lanes) or in the presence
of Hoechst 33342 (+H33342 lanes). Proteins were resolved by SDS-
PAGE, and 35S-labeled p34"xc2(Arg33) was visualized by autoradi-
ography and quantitated by Phosphorlmager. (B) HeLa cell lysates
prepared as described above were immunoprecipitated with anti-cyclin
B antiserum and precipitates were assayed for histone Hi kinase ac-
tivity. Shown is a plot of radioactivity incorporated into histone Hi
for control cells (U) and cells delayed in G2 (+H33342, 0).
saying cell lysates at selected time points for histone Hi
kinase activity associated with anti-cyclin B immuno-
precipitates (Figure 4B). Cells progressed into mitosis
10 h after release from the double thymidine block, and
exit from mitosis was complete by 13 h after the release.
Incubation of cells with Hoechst 33342 caused a sig-
nificant G2 delay. In Figure 4A, p34cdc2(Arg33) was
readily phosphorylated on Thr14 and Tyrl5 throughout
S phase and G2 phase, with >95% of p34cdc2(Arg33)
migrating with a reduced electrophoretic mobility.
Concomitant with entry of cells into mitosis, phos-
phorylation of p34cdc2(Arg33) at Thrl4 and Tyrl5 de-
creased to -50% of S and G2 phase levels. Finally, as
cells exited mitosis into Gl of the next cell cycle, phos-
phorylation of Thr14 and Tyr15 increased, reflecting
increased activity of the Thr14- and Tyrl5-specific ki-
nase(s). In the presence of H33342, entry into mitosis
was delayed (Figure 4B) and the Thr14- and Tyr15-
kinase activities remained elevated (Figure 4A).
Xenopus Egg Extracts also Possess Thrl4- and
Tyrl5-Specific Kinase Activities
Using the assay described above for HeLa cells, the
characteristics of the Thr14- and Tyr15-specific kinase
activities found in Xenopus egg extracts were examined.
Activated Xenopus egg extracts were arrested in inter-
phase by the addition of cycloheximide and assayed for
the ability to phosphorylate several mutant forms of
p34cdc2 in complex with GST-cyclin B (Figure 5A). Again,
phosphorylation of Thrl4 and/or Tyr15 was monitored
by a shift in electrophoretic mobility of p34cdc2. When
A
33R 14A 15F 14A15F
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-;3ii' < p34cdc2
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Figure 5. Characterization of Thr14- and Tyr15-specific kinase activ-
ities in Xenopus egg extracts. (A) Protein precipitates containing
p34cdc2(Arg33) (33R), p34Cdc2(Ala14) (14A), p34Cdc2(Phel5) (15F),p34cdc2(Ala14Phel5) (14A15F) in complex with GST-cyclin B were
prepared as described in Figure 1. p34cdc2/GST-cyclin B complexes
were incubated in the absence (-) or in the presence (+) of interphase
egg extracts (- 1 mg total protein). Proteins were resolved by SDS-
PAGE, and 35S-labeled p34cdc2 was visualized by autoradiography.
(B) (l5S)-p34 1c2(Arg33)/GST-cycin B complexes were isolated as de-
scribed in Figure 1. Precipitates were then incubated with varying
amounts of interphase egg extract (0-2 mg total protein). Proteins
were resolved by SDS-PAGE, and 35S-labeled p34cdc2 was visualized
by autoradiography.
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p34cdc2(Arg33) was incubated with interphase extract in
the presence of MgATP and vanadate, it was readily
phosphorylated on both Thrl4 and Tyr15, as indicated
by the appearance of two slower electrophoretic forms of
p34cdc2(Arg33) (Figure 5A; 33R). Similarly, p34cdc2
(Alal4) and p34cdc2(Phel5) were phosphorylated on
Tyrl5 and Thrl4, respectively, when incubated with
interphase extract, indicated by a single shift in electro-
phoretic mobility (Figure 5A; 14A and 15F). The altered
mobility observed after incubation of p34cdc2 with in-
terphase extract was due to phosphorylation of Thrl4
and/or Tyr15, as addition of interphase extract did not
alter the electrophoretic mobility of p34cdc2(Alal4Phel5)
(Figure 5A; 14A and 15F).
To assess the activity of the Xenopus Thr14- and
Tyrl5-kinases, phosphorylation of Thr14 and Tyrl5 was
assayed with varying amounts of Xenopus egg extract.
As shown in Figure 5B, the extent of phosphorylation
of p34cdc2(Arg33) increased with increasing amounts of
interphase extract, as measured by a decrease in elec-
trophoretic mobility. Phosphorylation of both Thrl4
and Tyr15 was detected with as little as 100 ,ug extract,
and maximal levels of phosphorylation were achieved
with 0.5 to 1.0 mg extract. Thus, as measured in this
assay, Xenopus egg extracts contain approximately twice
the level of Thrl4 and Tyrl5 kinase activities found in
HeLa cell lysates. However, it is unclear from these ex-
periments whether this difference reflects a difference
in the abundance of the Thrl4/Tyrl5 kinase(s), the ac-
tivity of the kinase(s), or simply the method by which
the extracts were prepared.
Cell Cycle Regulation of Thrl4- and Tyrl5-Specific
Kinase Activities in Xenopus Egg Extracts
Earlier studies of the phosphorylation state of p34cdc2
in Xenopus egg extracts suggested that the rate of phos-
phorylation of p34cdc2 on Tyrl5 is diminished in mitotic
versus interphase extracts (Solomon et al., 1990).
Smythe and Newport (1992) reported that Xenopus egg
extracts naturally arrested in M phase possessed less
p34cdc2-specific tyrosine kinase activity than extracts ar-
rested in S phase by the presence of aphidicolin (Smythe
and Newport, 1992). To assess both the Thrl4- and
Tyr15-specific kinase activities at different stages of the
cell cycle in Xenopus egg extracts, two approaches were
taken. In one case, CSF-arrested extracts (arrested in M
phase) were induced to enter interphase by the addition
of 0.4 mM CaCl2. Extract samples were removed at se-
lected time points after activation and incubated with(35S)p34cdc2(Arg33)/GST-cyclin B complexes, MgATP,
and vanadate (Figure 6A). The Thrl4- and Tyr15-kinase
activities were low in M phase extracts (Figure 6A, O').
Interestingly, both activities increased as early as 5 min
after exit fromM phase and remained relatively constant
as the extract progressed fully into interphase (Fig-
ure 6A).
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Figure 6. Cell cycle regulation of Thrl4- and Tyr15-specific kinase
activities in Xenopus egg extracts. (3"S)-p34cdc2(Arg33)/GST-cyclin B
precipitates were prepared as described in Figure 1. (A) CSF-arrested
egg extracts were activated with 0.4 mM CaCl2 and incubated at 23°C.
Aliquots of extract were removed at 5, 15, 30, and 60 min after ac-
tivation and then incubated for 45 min at 25°C with (35S)-
p34'(Arg33)/GST-cyclin B precipitates. (B) Interphase extracts were
prepared from Xenopus eggs as described in the MATERIALS AND
METHODS. Mitotic extracts were prepared by the addition of A90
cyclin (a nondegradable form of sea urchin cyclin B) to the interphase
extracts. (35S)-p34 c2(Arg33)/GST-cyclin B precipitates were incubated
in the interphase (lanes 2 to 5) and mitotic (lanes 6 to 9) extracts
for 5, 10, 15, and 30 min at room temperature. Lane 1: (35S)-
p34cdc2(Arg33)/GST-cychn B precipitates incubated in buffer alone
for 30 min at room temperature. (C) Interphase and mitotic extracts
were assayed for their ability to phosphorylate histone Hi. Lane 1:
interphase extract; lane 2: interphase extract incubated at 23°C for
50 min; lane 3: interphase extracts incubated at 23°C for 50 min in
the presence of A90 sea urchin cyclin B. Proteins were resolved by
SDS-PAGE, and 35S-labeled p34CdC2(Arg33) and 32P-labeled histone
Hi were visualized by autoradiography.
As a second approach, interphase extracts were pre-
pared and were induced to enter M-phase by the ad-
dition of a nondegradable form of sea urchin cyclin
B (Glotzer et al., 1991) (Figure 6, B and C). The ex-
tracts were then assayed for levels of histone Hi ki-
nase activity (Figure 6C) and were incubated with
(35S)p34Cdc2((Arg33)/GST-cyclin B complexes for various
periods of time as described above (Figure 6B). As seen
in Figure 6B (lanes 2-5), interphase extracts contained
Thrl4- and Tyrl5-kinase activities. However, when
these extracts were induced to enter a stable M-phase
state, a loss in both activities was observed (lanes 6 to
9). These results suggest that the Thr14- and Tyr15-
specific kinase activities are both activated immediately
upon exit of cells from mitosis, remain high throughout
interphase, and then decrease as cells progress from G2
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into mitosis. Thus the results obtained with Xenopus
egg extracts parallel those obtained for HeLa cells.
Characterization and Partial Purification of the
Thrl4/Tyrl5 Kinase(s) from Xenopus Extracts
We used the shift assay described above to begin pu-
rifying the Thr14 and Tyr15 kinases from interphase
extracts prepared from Xenopus eggs (Figure 7 and 8).
The assay requires the use of the p34cdc2/cycin B com-
plex because this is the preferred substrate for phos-
phorylation. Interphase extract was tested for its ability
to shift the electrophoretic mobility of (3SS)-p34cdc2 as
described previously (Figure 7A, lane 1). Alternatively,
interphase extract was centrifuged at 150 000 X g, and
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Figure 7. Identification of two activities in Xenopus interphase extracts
capable of phosphorylating p34c"c2. (A) ("S)-p34"(Arg33)/GST-cy
clin B purified on glutathione beads was incubated with interphase
extract prepared from Xenopus eggs (lane 1). Interphase extract was
centrifuged at 150 000 X g. The 150 000 X g supematant fraction
(lane 2) and the 150 000 X g pellet fraction [extracted with varying
concentrations of either Brij-35 (lanes 3-5) or Triton X (lanes 6 and
7)] were assayed for their ability to shift the electrophoretic mobility
of (35S)-p34-c2(3SS)-p34cdc2(Arg33)/GST-cycin B was resolved by
SDS-PAGE on a 12% gel. 35S-labeled p34(2 was visualized by au-
toradiography. Lane 1: interphase extract; lane 2: 150 000 X g super-
natant; lane 3: the 150 000 X g pellet was solubilized in 0.05% Brij-
35, recentrifuged at 150 000 X g, and the supematant was assayed;
lane 4: pellet from 3 was solubilized in 0.2% Brij-35, was recentrifuged
at 150 000 X g and the supematant was assayed; lane 5: pellet from
4 was solubilized in 0.5% Brij-35, was recentrifuged at 150 000 X g
and the supernatant was assayed; lane 6: 150 000 X g pellet was
solubilized in 0.1% Triton X, was recentrifuged at 150 000 X g, and
the supernatant was assayed; lane 7: pellet from 6 was solubilized in
0.5% Triton X, was recentrifuged at 150 000 X g, and the supematant
was assayed. (B) ("S)-p34 12(Arg33)/GST-cychn B purified on glu-
tathione beads was incubated with interphase extract, with the 150 000
X g supematant fraction (150S) or with the 150 000 X g pellet fraction
solubilized in 0.5% Brij-35 (150P0.5B). Reactions were stopped by
washing with phosphatase buffer and further incubated in the absence
(lanes 2, 4, and 6) or presence (lanes 3, 5, and 7) of PTP1. Lane 1:
substrate only. (35S)-p34cdc2(Arg33)/GST-cycin B was resolved by
SDS-PAGE on a 12% gel. 35S-labeled p34CiC2 was visualized by au-
toradiography.
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Figure 8. Partial purification of the Thrl4/Tyrl5 kinase(s) from Xen-
opus egg extract. Proteins solubilized from the 150 000 X g pellet were
fractionated through Q-Sepharose, S-Sepharose, and reactive yellow
3 columns. Various column fractions were assayed for the ability to
phosphorylate (3"S)-p34c"c2(Arg33)/GST-cyclin B complex. Proteins
were resolved by SDS-PAGE, and 35S-labeled p344xI2 was visualized
by autoradiography. (35S)-p34'(Arg33)/GST-cyclin B was incubated
with buffer (lane 1), the 150 000 X g pellet solubilized with 0.5% Brij-
35 (lane 2), the Q-Sepharose pool (lane 3), the S-Sepharose pool (lane
4), the reactive yellow 3 flowthrough (lane 5), and the fractions of
reactive yellow 3 gradient (lanes 6-14).
the supernatant fraction (Figure 7A, lane 2) or the pellet
fraction [extracted with varying concentrations of either
Brij-35 (lanes 3, 4, 5), or Triton X (lanes 6 and 7)] were
assayed for their ability to shift the electrophoretic mo-
bility of (3"S)-p34cdc2. The 150 000 X g supematant frac-
tion contained an activity capable of causing a single
shift in the electrophoretic mobility of p34cdc2 (this rep-
resents p34cdc2 singly phosphorylated on either Thrl4
or Tyr15). In contrast the 150 000 X g pellet contained
activities (that were extractable with either Brij-35 or
Triton X) that caused a double shift in the electrophoretic
mobility of p34cdc2. To further characterize these activ-
ities, phosphatase experiments were performed using
PTP1, a tyrosine-specific protein phosphatase from S.
cerevisiae (Figure 7B) (Hannig et al., 1993). p34cdc2/cyclin
B was incubated with interphase extracts (lanes 2 and
3), with the 150 000 X g supernatant (lanes 4 and 5) or
the 150 000 X g pellet that had been solubilized in 0.5%
Brij-35. p34cdc /cycin B was then incubated in phos-
phase buffer in the absence or the presence of PTP1.
In these experiments, Tyrl5 was dephosphorylated by
PTP1, whereas phosphorylated Thr14 remained intact.
These experiments demonstrated that the supernatant
fraction contained an activity that exclusively phos-
phorylated p34cdc2 on Tyrl5 (lanes 4 and 5), whereas
the pellet fraction contained activities capable of phos-
phorylating both Thrl4 and Tyrl5 (lanes 6 and 7).
To further characterize the detergent extractable ac-
tivity in the pellet fraction, we used the assay conditions
described above to partially purify the activities (Figure
8). The Thr14/Tyrl5 kinase activities were solubilized
from the 150 000 X g pellet by extraction with 0.5%
Brij-35 and tested for their ability to shift the electro-
phoretic mobility of p34cdc2 (lane 2). Extracts were ap-
plied to a Q-Sepharose anion exchange column. Bound
proteins were eluted with a gradient of NaCl (0.05 to
1 M), and fractions were assayed for their ability to shift
the electrophoretic mobility of p34cdc2. A single peak of
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activity (220 to 450 mM NaCI) was detected that cat-
alyzed the phosphorylation of both Thrl4 and Tyr15.
Peak fractions were pooled (lane 3), desalted on a
Sephadex G-25 column, and were then loaded onto an
S-Sepharose column. The Thr14/Tyrl5 kinase activities
were eluted from the column with 0.3 M NaCl. The S-
Sepharose fraction (lane 4) was desalted and further
applied to a reactive yellow 3 column. Proteins bound
to the yellow 3 column were eluted with a 0-1 M NaCl
gradient. Flow through (lane 5) and eluted fractions
(lanes 6-14) were tested in the shift assay described
above. Peak fractions of activity eluted between 0.15
and 0.4 M NaCl. Both Thrl4- and Tyr15-kinase activ-
ities co-purified through the three column steps.
DISCUSSION
This study describes the cell cycle regulation of the ki-
nase(s) responsible for phosphorylation of p34cdc2 on
both Thrl4 and Tyrl5. Phosphorylation of Thrl4 and/
or Tyri5 inhibits p34cdc2 kinase activity, and it is the
abrupt dephosphorylation of these residues that triggers
the activation of p34cdc2 and entry of cells into mitosis
(Dunphy and Newport, 1989; Gautier et al., 1989; Morla
et al., 1989; Solomon et al., 1990; Krek and Nigg, 1991;
Norbury et al., 1991). To monitor the phosphorylation
of Thrl4 and Tyr15, an assay was developed that relies
on the fact that phosphorylation of p34cdc2 on either
residue results in a decrease in its electrophoretic mo-
bility (Solomon et al., 1992). Phosphorylation of p34cdc2
on both residues leads to a further retardation in its
mobility (Solomon et al., 1992). Thus the state of phos-
phorylation of p34cdc2 (at Thrl4 and Tyr15) can be
monitored by changes in its electrophoretic mobility.
Based on this, 35S-labeled p34cdc2 (in complex with GST-
cyclin B) was used as a substrate for phosphorylation
by various cell lysates. By using 35S-labeled p34cdc2 as
a substrate, changes in electrophoretic mobility (due to
phosphorylation) were easily detected by autoradiog-
raphy. Furthermore, the Thr14- and Tyr15-specific ki-
nase activities could be examined individually by mon-
itoring changes in the electrophoretic mobility of mutant
forms of p34cdc2 in which either Thrl4 or Tyrl5
was changed to a nonphosphorylatable residue.
p34cdc2(Klal4) and p34cdc2(Phel5) each undergo a single
shift in electrophoretic mobility, indicative of phos-
phorylation of Tyrl5 and Thr14, respectively.
HeLa cells possess readily detectable Thrl4 and
Tyrl5 kinase activities, as evidenced by the phosphor-
ylation of p34cdc2(Arg33), as well as p34cdc2(Ala 14) and
p34cdc2(Phel5) in vitro (Figures 1-3). To examine the
Thrl4 and Tyr15 kinase activities across the cell cycle,
HeLa cells were synchronized by a double thymidine
block and then allowed to progress through G2, mitosis,
and into early G1. When synchronized cells were an-
alyzed at various stages of the cell cycle, it was observed
that both the Thrl4 and Tyrl5 kinase activities were
coordinately regulated in a cell cycle-dependent manner,
with both activities high until the G2/M transition (Fig-
ures 3 and 4). Upon entry of cells into mitosis, the Thr14-
and Tyr15-specific kinase activities were reduced. This
inactivation was reversed as cells exited mitosis and
progressed into G1. Interestingly, when HeLa cells were
arrested in mitosis by the addition of nocodazole, the
Thrl4 and Tyrl5 kinase activities were undetectable
(Figure 3). This exaggerated inhibition of the Thr14/
Tyrl5 kinase activities observed in nocodazole treated
cells might be the result of an extended arrest in mitosis,
leading to a cumulative inhibition or turn-over of the
Thrl4/Tyrl5 kinases.
The Thrl4 and Tyrl5 kinase activities were also ex-
amined in HeLa cells that were delayed in their pro-
gression through G2 by the DNA binding dye, Hoechst
33342. Hoechst 33342 binds to DNA, and interferes
with the proofreading mechanisms, which occur during
G2, thus delaying the initiation of mitosis (Crissman et
al., 1990). When Hoechst 33342 is added to cells fol-
lowing synchronization by a double thymidine block,
activation of histone Hi kinase activity is delayed by
>4 h relative to control cells, indicative of a delay in
entry into mitosis (Figure 4). Both Thrl4 and Tyrl5 spe-
cific kinase activities remained high throughout this ex-
tended G2 phase, thus maintaining p34cdc2 in its phos-
phorylated and inactive state. It is noteworthy that the
activity of the Thrl4/Tyrl5 kinase(s) did not increase
during the G2-induced delay, suggesting that normal
interphase levels of Thrl4 and Tyrl5 kinase activities
are sufficient to counteract any Cdc25 phosphatase ac-
tivity that may be present. In Xenopus, G2 delays in-
duced by the presence of unreplicated DNA have been
shown to stimulate the activity of Tyrl5 kinase (Smythe
and Newport, 1992) and more recently the Thrl4 kinase
(Kornbluth et al., 1994). Differences between the human
and Xenopus results may be explained if unreplicated
DNA and Hoechst binding to DNA operate to activate
distinct feedback control pathways. Addressing these
questions will be greatly facilitated once cDNAs encod-
ing the Xenopus and human Thrl4 and Tyrl5 kinases
are available.
It has been proposed that the abrupt activation of
p34cdc2/cyclin B at the G2/M transition is triggered by
the Cdc25 phosphatase, and that the activation of Cdc25
and p34cdc2 are intertwined in an autocatalytic loop
(Izumi et al., 1992; Kumagai and Dunphy, 1992; Clarke
et al., 1993; Hoffmann et al., 1993). According to this
model, Cdc25 dephosphorylates and activates p34cdc2,
which then phosphorylates and further activates Cdc25
to dephosphorylate p34cdc2, and so on. In fact, in Xen-
opus and humans, Cdc25 is activated by phosphoryla-
tion (Izumi et al., 1992; Kumagai and Dunphy, 1992;
Clarke et al., 1993; Hoffmann et al., 1993), and p34cdc2
is capable of phosphorylating and activating Cdc25 in
vitro (Hoffmann et al., 1993). Based on the results ob-
tained in this study as well as those reported by others
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(Smythe and Newport, 1992; Tang et al., 1993), it is
clear that the inactivation of Thr14 and Tyrl5 kinase
activities also plays a role in regulating the timing of
activation of p34cdc2 at G2/M. Accordingly, the state of
phosphorylation of p34cdc2 at Thrl4 and Tyrl5 is likely
determined by the balance of Thr14 and Tyrl5 kinase
activities and Cdc25 phosphatase activities during late
G2. Several possible mechanisms can be envisioned in
which the down-regulation of the Thr14/Tyrl5 ki-
nase(s) might combine with the activation of Cdc25 and
contribute to the rapid dephosphorylation and activa-
tion of p34cdc2. One model might be that Cdc25 and the
Thr14/Tyrl5 kinase(s) are regulated by independent
mechanisms which converge during late G2 to precisely
time the activation of p34cdc2/cyclin B. Alternatively,
Cdc25 and the Thr14/Tyr15 kinase(s) might share a
common regulator that is responsible for both activating
Cdc25 and inactivating the Thr14 and Tyrl5 kinase ac-
tivities at the G2/M transition. Interestingly, Cdc25
(from Xenopus and humans) has been shown to be ac-
tivated by phosphorylation (Izumi et al., 1992; Kumagai
and Dunphy, 1992; Clarke et al., 1993; Hoffmann et al.,
1993), while p107weel (from fission yeast) is inactivated
upon phosphorylation by the Cdrl/Niml kinase
(Coleman et al., 1993; Parker et al., 1993; Wu and Rus-
sell, 1993). Furthermore, Tang et al (1993) demonstrated
that fission yeast pl07eel is also phosphorylated and
inhibited when incubated with mitotic Xenopus egg ex-
tracts, suggesting that higher eukaryotes possess kinase
activity (distinct from the Cdrl/Niml kinase), which is
capable of down-regulating pl07"'D during M phase.
The present evidence indicates that the Thrl4 and Tyrl5
kinase activities of HeLa cells are inhibited in mitosis,
and one might predict by analogy that this inhibition
is due to phosphorylation of the Thrl4/Tyrl5 kinase(s).
In that case, a common regulatory kinase and/or phos-
phatase could simultaneously activate the Cdc25 phos-
phatase and inactivate the Thrl4/Tyrl5 kinase(s), thus
leading to an abrupt change in the phosphorylation state
of p34cdc2 at the G2/M transition. Most likely, a com-
bination of regulatory mechanisms is involved in the
precise control of the state of phosphorylation of p34cdc2
by Cdc25 and the Thr14/Tyrl5 kinase(s).
The regulation of Thrl4 and Tyri5 kinase activities
was examined in Xenopus egg extracts in addition to
HeLa cells. Like HeLa cells, Xenopus egg extracts con-
tained kinase activities capable of phosphorylating
p34cdc2 on both Thr14 and Tyr15. The Xenopus Thr14/
Tyrl5 kinase(s) also displayed a cell cycle dependent
regulation with low activity in M phase. In Xenopus egg
extracts, Thrl4 and Tyri5 kinase activities appeared
immediately upon exit from M phase and entry into
interphase. In addition, the activities were inhibited
when interphase extracts were driven into M-phase by
the addition of a nondegradable form of cyclin B. These
findings corroborate studies reported by Solomon et al.
(1990) and Smythe and Newport (1992), in which the
p34cdc2-specific tyrosine kinase activity of Xenopus egg
extracts was shown to decrease during mitosis. Of in-
terest in the present study is the fact that Thrl4-specific
kinase activity is also regulated in a cell cycle dependent
manner, and the regulation of its activity parallels that
of the Tyrl5-specific kinase activity. Similar results have
recently been reported by Kombluth et al. (1994). These
results suggest that Thrl4 and Tyri5 kinase activities
are regulated in a similar manner throughout the cell
cycle. Given that Thrl4 and Tyri5 specific kinase ac-
tivities are diminished during mitosis in both Xenopus
and HeLa cells, and that fission yeast plo07eel is also
inhibited in the context of an M phase extract (Tang et
al., 1993), down-regulation of the kinase(s) responsible
for the inhibitory phosphorylation of p34cdc2 may rep-
resent a conserved mechanism by which activation of
p34cdc2 and entry of cells into mitosis is regulated. Xen-
opus egg extracts should be readily amenable to dis-
secting the cell cycle regulation of the Thr14 and Tyrl5
kinases at the biochemical level.
To date, only a single human kinase capable of phos-
phorylating p34CdC2 on Tyrl5 and inhibiting the p34cdc2/
cyclin B complex has been identified (Honda et al., 1992;
Parker et al., 1992; McGowen and Russell, 1993). The
gene encoding this kinase (denoted WEE1Hu) was
identified in a genetic screen looking for functional ho-
mologs of weel+ (Igarashi et al., 1991). The kinase re-
sponsible for Thrl4 phosphorylation has not been
identified. We have detected two activities capable of
phosphorylating p34cdc2 on Thrl4 and Tyrl5 in inter-
phase extracts prepared from Xenopus eggs. An activity
capable of phosphorylating Tyrl5 remains soluble after
centrifugation of interphase extracts at 150 000 X g. A
second activity capable of phosphorylating both Thrl4
and Tyrl5 pellets during the 150 000 X g spin but is
detergent extractable. Similar findings have recently
been reported by Kombluth et al. (1994). We have begun
to biochemically purify the detergent extractable en-
zyme. The assay requires the use of the p34cdc2/cycin
B complex as this is the preferred substrate for phos-
phorylation. The kinases are detected in various frac-
tions based on their ability to cause a shift in the elec-
trophoretic mobility of p34cdc2 on SDS-gels. The kinases
co-purify through three successive chromatographic
steps. Further steps will be required to purify the en-
zyme(s) to homogeneity for future study, but the in-
triguing possibility exists that a dual-specificity kinase
capable of phosphorylating p34cdc2 on both Thrl4 and
Tyrl5 is present in higher eukaryotic cells.
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